CERETOX to present its R&D&I in toxicology potential at the UB-TECNIO Conference Blog Post

The UB-TECNIO Conference on Food, Health Sciences and Industrial Systems is to be held at the Barcelona Science Park (PCB) on Tuesday 13 February. The event is organised by the Bosch i Gimpera Foundation (FBG) and will present UB Group TECNIO group and candidate technology to companies which have innovation and development requirements for new products and services. CERETOX is integrated by the PCB’s Experimental Toxicology and Ecotoxicology Technology Platform (UTOX) and the Toxicology Unit of the Faculty of Pharmacy of the University of Barcelona and will be one of the research centres to showcase its potential in R&D&I services for companies.

 

The FBG awards €100,000 to four UB projects for the valorisation of research Blog Post

On 18 January, the FBG, located at PCB, presented the grants of the Valorisation Fund (FVal) of the Fund for the Promotion of Innovation (F2i). Within this funding programme, € 25,000 were awarded to each selected project, which will be used to valorize projects of the University of Barcelona with a high potential for transfer and impact on our society. 

 

SOLVE-RD: Major European grant for research into rare diseases Blog Post

The CNAG-CRG at PCB participates in a large consortium led by the University of Tübingen, the Radboud University Medical Center Nijmegen and the University of Leicester that has acquired a € 15 million grant for the SOLVE-RD research program he researchers will work directly with four European Reference Networks (ERNs) to share and enhance the knowledge and resources used for treating rare diseases.

 

Chemotargets signs a research collaboration agreement with FDA/CDER Blog Post

The Food and Drug Administration’s Center for Drug Evaluation and Research (FDA-CDER) and Chemotargets –a spin off from the IMIM Hospital del Mar Medical Research Institut and located at the Barcelona Science Park– will work together under a 5-year Research Collaboration Agreement (RCA). The collaboration aims to enhance CDER’s safety assessments of human pharmaceuticals, supporting the FDA’s mission of protecting public health.

 

Esteve picks up Company of the Year Award Blog Post

Esteve has won the Company of the Year Award 2017 which is sponsored by Grupo Zeta and Banc Sabadell and recognises contributions to creating wellbeing and progress. The pharmaceutical chemical group, which has its Drug Discovery and Preclinical Development Units at the Barcelona Science Park, is a leader in the international pharmaceutical industry due to its continuous innovation in the traditional R&D model and unswerving commitment to promoting excellence in research ecosystems. Albert Esteve, the company’s Chairman, is to collect the award today at Casa Llotja de Mar in Barcelona at a ceremony attended by a wide range of political, social and industry figures.

 

Bioinformatics company Mind the Byte acquires Intelligent Pharma Blog Post

Mind the Byte a pioneer in the development of technologies based on artificial intelligence, cloud and big data for computational drug design, has acquired 100% of Intelligent Pharma, one of the leaders in Spain in chemoinformatics services for the pharmaceutical and biotechnology industry. Both bioinformatics companyies are headquartered in the Barcelona Science Park (Parc Científic de Barcelona, PCB) which will help the integration process under which Mind the Byte expects to reach €2 million in turnover by 2019.